# EDGAR Filing Document

**Accession Number:** 0001970751
**File Stem:** 0001193125-26-251691
**Filing Date:** 2026-6
**Character Count:** 31121
**Document Hash:** 3b756d715177fb5f86947d28c1c22ea6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-251691.hdr.sgml**: 20260601

**ACCESSION NUMBER**: 0001193125-26-251691

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260601

**DATE AS OF CHANGE**: 20260601

**PERIOD START**: 20261231

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Advisor Managed Portfolios
- **CENTRAL INDEX KEY:** 0001970751

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-23859
- **FILM NUMBER:** 261052116

**BUSINESS ADDRESS:**
- **STREET 1:** 615 EAST MICHIGAN STREET
- **CITY:** MILWAUKEE
- **STATE:** WI
- **ZIP:** 53202
- **BUSINESS PHONE:** (626) 914-7385

**MAIL ADDRESS:**
- **STREET 1:** 615 EAST MICHIGAN STREET
- **CITY:** MILWAUKEE
- **STATE:** WI
- **ZIP:** 53202

## Series and Classes Contracts Data

### Patient Opportunity Trust (Series ID: S000082973)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000246405 | Class R      | LMORX           |
| C000246406 | Class FI     | LMOFX           |
| C000246407 | Class A      | LGOAX           |
| C000246408 | Class I      | LMNOX           |
| C000246409 | Class C      | LMOPX           |
| C000246410 | Class IS     | MVISX           |

## Nport-Ex

---

| | | | |
|:---|:---|:---|:---|
| **Patient Opportunity Trust** | **Patient Opportunity Trust** | **Patient Opportunity Trust** | **Patient Opportunity Trust** |
| **Consolidated Schedule of Investments** | **Consolidated Schedule of Investments** | **Consolidated Schedule of Investments** | **Consolidated Schedule of Investments** |
| **March 31, 2026 (Unaudited)** | **March 31, 2026 (Unaudited)** | **March 31, 2026 (Unaudited)** | **March 31, 2026 (Unaudited)** |
| **COMMON STOCKS - 103.3%** | **COMMON STOCKS - 103.3%** | **Shares**  | **Value**  |
| **<u>Communication Services</u> - 14.6%** | **<u>Communication Services</u> - 14.6%** | **<u>Communication Services</u> - 14.6%** | |
| **Interactive Media & Services - 14.2%** | **Interactive Media & Services - 14.2%** | | |
| Alphabet, Inc. - Class A<sup>(h)</sup> | Alphabet, Inc. - Class A<sup>(h)</sup> | 380000 | $109272800 |
| IAC, Inc. <sup>(a) (h)</sup> | IAC, Inc. <sup>(a) (h)</sup> | 1800000 | 72054000 |
| Meta Platforms, Inc. - Class A<sup>(h)</sup> | Meta Platforms, Inc. - Class A<sup>(h)</sup> | 115000 | 65794950 |
|  |  |  | 247121750 |
| **Media - 0.4%** | **Media - 0.4%** |  |  |
| S4 Capital PLC | S4 Capital PLC | 19000000 | 6991211 |
| **Total Communication Services** | **Total Communication Services** | **Total Communication Services** | 254112961 |
| **<u>Consumer Discretionary</u> - 17.7%** | **<u>Consumer Discretionary</u> - 17.7%** | **<u>Consumer Discretionary</u> - 17.7%** |  |
| **Automobiles - 2.1%** | **Automobiles - 2.1%** |  |  |
| General Motors Co. | General Motors Co. | 500000 | 37250000 |
| **Broadline Retail - 6.8%** | **Broadline Retail - 6.8%** |  |  |
| Amazon.com, Inc. <sup>(a) (h)</sup> | Amazon.com, Inc. <sup>(a) (h)</sup> | 455000 | 94762850 |
| JD.com, Inc. - ADR | JD.com, Inc. - ADR | 800000 | 23656000 |
|  |  |  | 118418850 |
| **Hotels, Restaurants & Leisure - 6.0%** | **Hotels, Restaurants & Leisure - 6.0%** |  |  |
| Dave & Buster's Entertainment, Inc. <sup>(a)</sup> | Dave & Buster's Entertainment, Inc. <sup>(a)</sup> | 750000 | 8122500 |
| Expedia Group, Inc. | Expedia Group, Inc. | 110000 | 25397900 |
| Norwegian Cruise Line Holdings Ltd. <sup>(a) (h)</sup> | Norwegian Cruise Line Holdings Ltd. <sup>(a) (h)</sup> | 3800000 | 71060000 |
|  |  |  | 104580400 |
| **Textiles, Apparel & Luxury Goods - 2.8%** | **Textiles, Apparel & Luxury Goods - 2.8%** |  |  |
| Crocs, Inc. <sup>(a)</sup> | Crocs, Inc. <sup>(a)</sup> | 575000 | 47736500 |
| **Total Consumer Discretionary** | **Total Consumer Discretionary** | **Total Consumer Discretionary** | 307985750 |
| **<u>Energy</u> - 11.1%** | **<u>Energy</u> - 11.1%** | **<u>Energy</u> - 11.1%** |  |
| **Energy Equipment & Services - 6.4%** | **Energy Equipment & Services - 6.4%** |  |  |
| Noble Corp. PLC | Noble Corp. PLC | 850000 | 41709500 |
| Seadrill Ltd. <sup>(a)</sup> | Seadrill Ltd. <sup>(a)</sup> | 1523039 | 69298275 |
|  |  |  | 111007775 |
| **Oil, Gas & Consumable Fuels - 4.7%** | **Oil, Gas & Consumable Fuels - 4.7%** |  |  |
| Energy Transfer LP <sup>(h)</sup> | Energy Transfer LP <sup>(h)</sup> | 4200000 | 81060000 |
| **Total Energy** | **Total Energy** | **Total Energy** | 192067775 |
| **<u>Financials</u> - 17.8%** | **<u>Financials</u> - 17.8%** | **<u>Financials</u> - 17.8%** |  |
| **Banks - 6.5%** | **Banks - 6.5%** |  |  |
| Citigroup, Inc. <sup>(h)</sup> | Citigroup, Inc. <sup>(h)</sup> | 1000000 | 113410000 |
| **Capital Markets - 4.7%** | **Capital Markets - 4.7%** |  |  |
| Coinbase Global, Inc. - Class A <sup>(a)</sup> | Coinbase Global, Inc. - Class A <sup>(a)</sup> | 275000 | 48017750 |
| UBS Group AG | UBS Group AG | 850000 | 33209500 |
|  |  |  | 81227250 |
| **Consumer Finance - 2.5%** | **Consumer Finance - 2.5%** |  |  |
| OneMain Holdings, Inc. | OneMain Holdings, Inc. | 550000 | 29419500 |
| SoFi Technologies, Inc. <sup>(a)</sup> | SoFi Technologies, Inc. <sup>(a)</sup> | 880000 | 13974400 |
|  |  |  | 43393900 |
| **Financial Services - 4.1%** | **Financial Services - 4.1%** |  |  |
| Chime Financial, Inc. - Class A <sup>(a)</sup> | Chime Financial, Inc. - Class A <sup>(a)</sup> | 1900000 | 35587000 |
| Fiserv, Inc. <sup>(a)</sup> | Fiserv, Inc. <sup>(a)</sup> | 625000 | 34875000 |
|  |  |  | 70462000 |
| **Total Financials** | **Total Financials** | **Total Financials** | 308493150 |
| **<u>Health Care</u> - 24.5% <sup>(b)</sup>** | **<u>Health Care</u> - 24.5% <sup>(b)</sup>** | **<u>Health Care</u> - 24.5% <sup>(b)</sup>** |  |
| **Biotechnology - 5.6%** | **Biotechnology - 5.6%** |  |  |
| Biogen, Inc. <sup>(a) (h)</sup> | Biogen, Inc. <sup>(a) (h)</sup> | 250000 | 45832500 |
| Precigen, Inc. <sup>(a) (c)</sup> | Precigen, Inc. <sup>(a) (c)</sup> | 12900000 | 49923000 |
|  |  |  | 95755500 |
| **Health Care Providers & Services - 8.5%** | **Health Care Providers & Services - 8.5%** |  |  |
| CVS Health Corp. <sup>(h)</sup> | CVS Health Corp. <sup>(h)</sup> | 925000 | 66433500 |
| UnitedHealth Group, Inc. <sup>(h)</sup> | UnitedHealth Group, Inc. <sup>(h)</sup> | 300000 | 81177000 |
|  |  |  | 147610500 |
| **Life Sciences Tools & Services - 3.5%** | **Life Sciences Tools & Services - 3.5%** |  |  |
| Illumina, Inc. <sup>(a) (h)</sup> | Illumina, Inc. <sup>(a) (h)</sup> | 390000 | 48071400 |
| Tempus AI, Inc. - Class A <sup>(a)</sup> | Tempus AI, Inc. - Class A <sup>(a)</sup> | 285000 | 12887700 |
|  |  |  | 60959100 |
| **Pharmaceuticals - 6.9%** | **Pharmaceuticals - 6.9%** |  |  |
| Royalty Pharma PLC - Class A <sup>(h)</sup> | Royalty Pharma PLC - Class A <sup>(h)</sup> | 2500000 | 119925000 |
| **Total Health Care** | **Total Health Care** | **Total Health Care** | 424250100 |
| **<u>Industrials</u> - 9.8%** | **<u>Industrials</u> - 9.8%** | **<u>Industrials</u> - 9.8%** |  |
| **Passenger Airlines - 4.2%** | **Passenger Airlines - 4.2%** |  |  |
| Delta Air Lines, Inc. | Delta Air Lines, Inc. | 395000 | 26259600 |
| United Airlines Holdings, Inc. <sup>(a)</sup> | United Airlines Holdings, Inc. <sup>(a)</sup> | 500000 | 46035000 |
|  |  |  | 72294600 |
| **Trading Companies & Distributors - 5.6%** | **Trading Companies & Distributors - 5.6%** |  |  |
| QXO, Inc. <sup>(a) (h)</sup> | QXO, Inc. <sup>(a) (h)</sup> | 5000000 | 97100000 |
| **Total Industrials** | **Total Industrials** | **Total Industrials** | 169394600 |
| **<u>Information Technology</u> - 7.8%** | **<u>Information Technology</u> - 7.8%** | **<u>Information Technology</u> - 7.8%** |  |
| **Semiconductors & Semiconductor Equipment - 5.0%** | **Semiconductors & Semiconductor Equipment - 5.0%** |  |  |
| NVIDIA Corp. <sup>(h)</sup> | NVIDIA Corp. <sup>(h)</sup> | 500000 | 87200000 |
| **Software - 2.8%** | **Software - 2.8%** |  |  |
| Adobe, Inc. <sup>(a)</sup> | Adobe, Inc. <sup>(a)</sup> | 200000 | 48616000 |
| **Total Information Technology** | **Total Information Technology** | **Total Information Technology** | 135816000 |
| **TOTAL COMMON STOCKS** (Cost $1,189,529,834) | **TOTAL COMMON STOCKS** (Cost $1,189,529,834) | **TOTAL COMMON STOCKS** (Cost $1,189,529,834) | 1792120336 |
| **WARRANTS - 3.3%** | **WARRANTS - 3.3%** | **Contracts**  | **Value**  |
| **Health Care *-* 3.3% <sup>(b)</sup>** | **Health Care *-* 3.3% <sup>(b)</sup>** | **Health Care *-* 3.3% <sup>(b)</sup>** |  |
| Precigen Warrant Restricted, Expires 12/30/2034, Exercise Price $0.75 (Acquired 12/30/2024, Cost $9,022,725)<sup>(a)(c)(d)(e)</sup> | Precigen Warrant Restricted, Expires 12/30/2034, Exercise Price $0.75 (Acquired 12/30/2024, Cost $9,022,725)<sup>(a)(c)(d)(e)</sup> | 13600000 | 56712000 |
| **TOTAL WARRANTS** (Cost $9,022,725) | **TOTAL WARRANTS** (Cost $9,022,725) | **TOTAL WARRANTS** (Cost $9,022,725) | 56712000 |
| **EXCHANGE TRADED FUNDS - 2.4%** | **EXCHANGE TRADED FUNDS - 2.4%** | **Shares**  | **Value**  |
| iShares Bitcoin Trust ETF <sup>(a) (i)</sup> | iShares Bitcoin Trust ETF <sup>(a) (i)</sup> | 1100000 | 42262000 |
| **TOTAL EXCHANGE TRADED FUNDS** (Cost $44,845,256) | **TOTAL EXCHANGE TRADED FUNDS** (Cost $44,845,256) | **TOTAL EXCHANGE TRADED FUNDS** (Cost $44,845,256) | 42262000 |
| **PURCHASED OPTIONS - 0.5% <sup>(a)</sup>** | **Notional Amount**  | **Contracts**  | **Value**  |
| **Call Options - 0.5%** | **Call Options - 0.5%** |  |  |
|  Biogen, Inc., Expiration: 01/21/2028; Exercise Price: $150.00 <sup>(f)(g)</sup> | 27884493 | 1521 | 9430200 |
| **TOTAL PURCHASED OPTIONS** (Cost $5,829,199) | **TOTAL PURCHASED OPTIONS** (Cost $5,829,199) | **TOTAL PURCHASED OPTIONS** (Cost $5,829,199) | 9430200 |
| **TOTAL INVESTMENTS - 109.5% (**Cost $1,249,227,014**)** | **TOTAL INVESTMENTS - 109.5% (**Cost $1,249,227,014**)** | **TOTAL INVESTMENTS - 109.5% (**Cost $1,249,227,014**)** | 1900524536 |
| Liabilities in Excess of Other Assets - (9.5)% | Liabilities in Excess of Other Assets - (9.5)% | Liabilities in Excess of Other Assets - (9.5)% | (165574463) |
| **TOTAL NET ASSETS - 100.0%** |  |  | $1734950073 |
| Percentages are stated as a percent of net assets. | Percentages are stated as a percent of net assets. | Percentages are stated as a percent of net assets. |  |

---

---

| |
|:---|
| ADR - American Depositary Receipt |
| LP - Limited Partnership |
| PLC - Public Limited Company |
| The Global Industry Classification Standard ("GICS<sup>®</sup>") was developed by and/or is the exclusive property of MSCI, Inc. ("MSCI") and Standard & Poor's Financial Services LLC ("S&P"). GICS<sup>®</sup> is a service mark of MSCI and S&P and has been licensed for use by U.S. Bank Global Fund Services. |

---

(a) Non-income producing security.

(b) To the extent that the Fund invests more heavily in a particular industry or sector of the economy, its performance will be especially sensitive to developments that significantly affect those industries or sectors.

(c) Affiliated security as defined by the Investment Company Act of 1940.

(d) Fair value determined using significant unobservable inputs in accordance with procedures established by and under the supervision of the Adviser, acting as Valuation Designee. These securities represented
 $56,712,000 or 3.3% of net assets as of March 31, 2026.

(e) Security is considered restricted. The total market value of these securities was $56,712,000 which represented 3.3% of net assets as of March 31, 2026.

(f) Exchange-traded.

(g) 100 shares per contract.

(h) All or a portion of this security is pledged as collateral pursuant to the loan agreement.

(i) Position held in Cayman Subsidiary.

------

#### Summary of Fair Value Disclosure as of March 31, 2026 (Unaudited)
Patient Opportunity Trust (the "Fund") has adopted fair value accounting standards which establish a definition of fair value and set out a hierarchy for measuring fair value. These standards require additional disclosures about the various inputs and valuation techniques used to develop the measurements of fair value, a discussion of changes in valuation techniques and related inputs during the period, and expanded disclosure of valuation levels for major security types. These inputs are summarized in the three broad levels listed below. The inputs or valuation methodology used for valuing securities are not an indication of the risk associated with investing in those securities.

Level 1 - Unadjusted quoted prices in active markets for identical assets or liabilities that the Fund has the ability to access.

Level 2 - Observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These inputs may include quoted prices for the identical instrument on an inactive market, prices for similar instruments, interest rates, prepayment speeds, credit risk, yield curves, default rates and similar data.

Level 3 - Unobservable inputs for the asset or liability, to the extent relevant observable inputs are not available, representing the Fund's own assumptions about the assumptions a market participant would use in valuing the asset or liability, and based on the best information available.

The following is a summary of the fair valuation hierarchy of the Fund's securities as of March 31, 2026:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **<u>Level 1</u>** | **<u>Level 2</u>** | **<u>Level 3</u>** | **<u>Total</u>** |
| <u>Investments:</u> |  |  |  |  |
|  &nbsp;&nbsp;&nbsp;&nbsp;Common Stocks | $1792120336 | $– | $– | $1792120336 |
|  &nbsp;&nbsp;&nbsp;&nbsp;Warrants | – | – | 56712000 | 56712000 |
|  &nbsp;&nbsp;&nbsp;&nbsp;Exchange Traded Funds | 42262000 | – | – | 42262000 |
|  &nbsp;&nbsp;&nbsp;&nbsp;Purchased Options | – | 9430200 | – | 9430200 |
| Total Investments | $1834382336 | $9430200 | $56712000 | $1900524536 |
| Refer to the Schedule of Investments for further disaggregation of investment categories. | Refer to the Schedule of Investments for further disaggregation of investment categories. | Refer to the Schedule of Investments for further disaggregation of investment categories. | Refer to the Schedule of Investments for further disaggregation of investment categories. | Refer to the Schedule of Investments for further disaggregation of investment categories. |

---

---

| | |
|:---|:---|
| **Fair Value Measurement Using Significant Unobservable Inputs** | **<u>Level 3</u>** |
| Beginning balance as of December 31, 2025 | $60520000 |
| Change in unrealized depreciation | (3808000) |
| Ending balance as of March 31, 2026 | $56712000 |
|  | $0 |
| Change in unrealized appreciation/depreciation still held as of March 31, 2026 | $(3808000) |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **<u>Description</u>** | **<u>Fair Value as of</u>**<br>  **<u>March 31, 2026</u>** | **<u>Valuation Technique</u>** | **<u>Unobservable Inputs</u>** | **<u>Range Weighted<br> Average</u>** |
| Warrants | $56712000 | Black Scholes with Probability Adjustment | Going Concern Probability | 15% |
|  | $**56712000** |  |  |  |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Patient Opportunity Trust - Transactions with Affiliates** | **Patient Opportunity Trust - Transactions with Affiliates** | **Patient Opportunity Trust - Transactions with Affiliates** | **Patient Opportunity Trust - Transactions with Affiliates** | **Patient Opportunity Trust - Transactions with Affiliates** | **Patient Opportunity Trust - Transactions with Affiliates** | **Patient Opportunity Trust - Transactions with Affiliates** | **Patient Opportunity Trust - Transactions with Affiliates** | **Patient Opportunity Trust - Transactions with Affiliates** | |
|  | **Value as of**<br> **December 31, 2025** | **Additions** | **Reductions** | **Realized**<br> **Gain (Loss)** | **Net Change in Unrealized**<br> **Appreciation (Depreciation)** | **Value as of**<br> **March 31, 2026** | **Shares as of**<br> **March 31, 2026** | **Dividend /** <br> **Interest Income** |<br>**Capital Gain Distributions** <br> **from**<br> **Underlying Funds** |
| Precigen Inc. <sup>(a)</sup> | $58593619 | $– | $(4960713) | $4064404 | $(7774310) | $49923000 | 12900000 | $– | $– |
| Precigen Warrant Restricted | 60520000 | – | – | – | (3808000) | 56712000 | 13600000 | – | – |
|  | $**119113619** | $**–** | $**(4960713)** | $**4064404** | $**(11582310)** | $**106635000** | **26500000** | $**–** | $**–** |

---

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Advisor Managed Portfolios

- **b. Investment Company Act file number:** 811-23859

- **c. CIK number of Registrant:** 0001970751

- **d. LEI of Registrant:** 529900AK253W8LJALD89

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 615 East Michigan Street

  - **City:** Milwaukee

  - **State:** WI

  - **Foreign country:** US

  - **Zip / Postal Code:** 53202-5210

  - **Telephone number:** 4142873700

**Item A.2. Information about the Series.**

- **a. Name of Series:** Patient Opportunity Trust

- **b. EDGAR series identifier (if any):** S000082973

- **c. LEI of Series:** 529900SMRCCJER62MX98

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-12-31

- **b. Date as of which information is reported:** 2026-03-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $1911329848.79

**Total Liabilities:** $175970608.43

**Net Assets:** $1735359240.36

**Amount of Assets Invested in Other Investment Companies:** $42263636.64

**Cash Not Reported:** $684383.74

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000246405 | 2.45%                | -2.94%               | -5.55%               |
| Class ID C000246406 | 2.45%                | -2.92%               | -5.53%               |
| Class ID C000246407 | 2.47%                | -2.92%               | -5.53%               |
| Class ID C000246408 | 2.50%                | -2.89%               | -5.50%               |
| Class ID C000246409 | 2.41%                | -2.97%               | -5.59%               |
| Class ID C000246410 | 2.49%                | -2.88%               | -5.49%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $23994796.26             | $18784637.06                               |
| Month 2  | $-11285342.73            | $-36330722.68                              |
| Month 3  | $-7386888.11             | $-92099873.04                              |

### Schedule of Portfolio Investments

| Name                           | Title                              | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Adobe Inc                      | Adobe Inc                          | CUSIP: 00724F101<br>LEI: FU4LY2G4933NH2E1CP29 | Long             | EC               | CORP              | US        |    200000 | NS      | $48616000.00  | 2.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Alphabet Inc                   | Alphabet Inc                       | CUSIP: 02079K305<br>LEI: 5493006MHB84DD0ZWV18 | Long             | EC               | CORP              | US        |    380000 | NS      | $109272800.00 | 6.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Amazon.com Inc                 | Amazon.com Inc                     | CUSIP: 023135106<br>LEI: ZXTILKJKG63JELOEG630 | Long             | EC               | CORP              | US        |    455000 | NS      | $94762850.00  | 5.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Biogen Inc                     | Biogen Inc                         | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |    250000 | NS      | $45832500.00  | 2.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Chime Financial Inc            | Chime Financial Inc                | CUSIP: 16935C109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1900000 | NS      | $35587000.00  | 2.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Citigroup Inc                  | Citigroup Inc                      | CUSIP: 172967424<br>LEI: 6SHGI4ZSSLCXXQSBB395 | Long             | EC               | CORP              | US        |   1000000 | NS      | $113410000.00 | 6.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Coinbase Global Inc            | Coinbase Global Inc                | CUSIP: 19260Q107<br>LEI: 5493004G3J2SC154DU06 | Long             | EC               | CORP              | US        |    275000 | NS      | $48017750.00  | 2.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Crocs Inc                      | Crocs Inc                          | CUSIP: 227046109<br>LEI: 549300B0J6YCXD63OG72 | Long             | EC               | CORP              | US        |    575000 | NS      | $47736500.00  | 2.75%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group Inc         | UnitedHealth Group Inc             | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |    300000 | NS      | $81177000.00  | 4.68%             |  |  |  | No            |                  1 | On Loan: No      |
| CVS Health Corp                | CVS Health Corp                    | CUSIP: 126650100<br>LEI: 549300EJG376EN5NQE29 | Long             | EC               | CORP              | US        |    925000 | NS      | $66433500.00  | 3.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Dave & Buster's Entertainment  | Dave & Buster's Entertainment Inc  | CUSIP: 238337109<br>LEI: 529900WTVU85QZLYHR86 | Long             | EC               | CORP              | US        |    750000 | NS      | $8122500.00   | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Delta Air Lines Inc            | Delta Air Lines Inc                | CUSIP: 247361702<br>LEI: Q2CCMS6R0AS67HJMBN42 | Long             | EC               | CORP              | US        |    395000 | NS      | $26259600.00  | 1.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Energy Transfer LP             | Energy Transfer LP                 | CUSIP: 29273V100<br>LEI: MTLVN9N7JE8MIBIJ1H73 | Long             | EC               | CORP              | US        |   4200000 | NS      | $81060000.00  | 4.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Expedia Group Inc              | Expedia Group Inc                  | CUSIP: 30212P303<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    110000 | NS      | $25397900.00  | 1.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Meta Platforms Inc             | Meta Platforms Inc                 | CUSIP: 30303M102<br>LEI: BQ4BKCS1HXDV9HN80Z93 | Long             | EC               | CORP              | US        |    115000 | NS      | $65794950.00  | 3.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Fiserv Inc                     | Fiserv Inc                         | CUSIP: 337738108<br>LEI: GI7UBEJLXYLGR2C7GV83 | Long             | EC               | CORP              | US        |    625000 | NS      | $34875000.00  | 2.01%             |  |  |  | No            |                  1 | On Loan: No      |
| General Motors Co              | General Motors Co                  | CUSIP: 37045V100<br>LEI: 54930070NSV60J38I987 | Long             | EC               | CORP              | US        |    500000 | NS      | $37250000.00  | 2.15%             |  |  |  | No            |                  1 | On Loan: No      |
| IAC Inc                        | IAC Inc                            | CUSIP: 44891N208<br>LEI: 549300TO56L57RP6P031 | Long             | EC               | CORP              | US        |   1800000 | NS      | $72054000.00  | 4.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Illumina Inc                   | Illumina Inc                       | CUSIP: 452327109<br>LEI: SQ95QG8SR5Q56LSNF682 | Long             | EC               | CORP              | US        |    390000 | NS      | $48071400.00  | 2.77%             |  |  |  | No            |                  1 | On Loan: No      |
| iShares Bitcoin Trust ETF      | iShares Bitcoin Trust ETF          | CUSIP: 46438F101<br>LEI: 529900HVFN08L8P4H851 | Long             | EC               | RF                | US        |   1100000 | NS      | $42262000.00  | 2.44%             |  |  |  | No            |                  1 | On Loan: No      |
| JD.com Inc                     | JD.com Inc                         | CUSIP: 47215P106<br>LEI: 549300HVTWB0GJZ16V92 | Long             | EC               | CORP              | CN        |    800000 | NS      | $23656000.00  | 1.36%             |  |  |  | No            |                  1 | On Loan: No      |
| NVIDIA Corp                    | NVIDIA Corp                        | CUSIP: 67066G104<br>LEI: 549300S4KLFTLO7GSQ80 | Long             | EC               | CORP              | US        |    500000 | NS      | $87200000.00  | 5.02%             |  |  |  | No            |                  1 | On Loan: No      |
| OneMain Holdings Inc           | OneMain Holdings Inc               | CUSIP: 68268W103<br>LEI: 549300E3VEW8SMS5XW09 | Long             | EC               | CORP              | US        |    550000 | NS      | $29419500.00  | 1.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Precigen Inc                   | Precigen Inc                       | CUSIP: 74017N105<br>LEI: 549300XCWNQU35K64G19 | Long             | EC               | CORP              | US        |  12900000 | NS      | $49923000.46  | 2.88%             |  |  |  | No            |                  1 | On Loan: No      |
| QXO Inc                        | QXO Inc                            | CUSIP: 82846H405<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   5000000 | NS      | $97100000.00  | 5.60%             |  |  |  | No            |                  1 | On Loan: No      |
| SoFi Technologies Inc          | SoFi Technologies Inc              | CUSIP: 83406F102<br>LEI: 549300SW81JCMVZDDY09 | Long             | EC               | CORP              | US        |    880000 | NS      | $13974400.00  | 0.81%             |  |  |  | No            |                  1 | On Loan: No      |
| Tempus AI Inc                  | Tempus AI Inc                      | CUSIP: 88023B103<br>LEI: 2549009LA0KWRAGQBX50 | Long             | EC               | CORP              | US        |    285000 | NS      | $12887700.00  | 0.74%             |  |  |  | No            |                  1 | On Loan: No      |
| United Airlines Holdings Inc   | United Airlines Holdings Inc       | CUSIP: 910047109<br>LEI: 98450079DA0B78DD6764 | Long             | EC               | CORP              | US        |    500000 | NS      | $46035000.00  | 2.65%             |  |  |  | No            |                  1 | On Loan: No      |
| Precigen Warrant Restricted    | Precigen Warrant Restricted        | CUSIP: N/A<br>LEI: N/A                        | N/A              | DE               | CORP              | US        |  13600000 | NS      | $56712000.00  | 3.27%             |  |  |  | Yes           |                  3 | On Loan: No      |
| S4 Capital PLC                 | S4 Capital PLC                     | CUSIP: N/A<br>LEI: 21380068SP9V65KPQN68       | Long             | EC               | CORP              | GB        |  19000000 | NS      | $6991211.35   | 0.40%             |  |  |  | No            |                  1 | On Loan: No      |
| N/A                            | Biogen Inc                         | CUSIP: N/A<br>LEI: N/A                        | N/A              | DE               |  | US        |      1521 | NC      | $9430200.00   | 0.54%             |  |  |  | No            |                  2 | On Loan: No      |
| Noble Corp PLC                 | Noble Corp PLC                     | CUSIP: N/A<br>LEI: 549300I3HBUNXO0OG954       | Long             | EC               | CORP              | US        |    850000 | NS      | $41709500.00  | 2.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Norwegian Cruise Line Holdings | Norwegian Cruise Line Holdings Ltd | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | US        |   3800000 | NS      | $71060000.00  | 4.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Royalty Pharma PLC             | Royalty Pharma PLC                 | CUSIP: N/A<br>LEI: 549300FGFN7VOK8BZR03       | Long             | EC               | CORP              | US        |   2500000 | NS      | $119925000.00 | 6.91%             |  |  |  | No            |                  1 | On Loan: No      |
| Seadrill Ltd                   | Seadrill Ltd                       | CUSIP: N/A<br>LEI: 213800EQ6L456U2JCO89       | Long             | EC               | CORP              | BM        |   1525000 | NS      | $69387500.00  | 4.00%             |  |  |  | No            |                  1 | On Loan: No      |
| UBS Group AG                   | UBS Group AG                       | CUSIP: N/A<br>LEI: 549300SZJ9VS8SGXAN81       | Long             | EC               | CORP              | CH        |    850000 | NS      | $33209500.00  | 1.91%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-05-29

**Name of Applicant:** Advisor Managed Portfolios

**Signature:** /s/ Eric T. McCormick

**Name of Signer:** Advisor Managed Portfolios

**Title:** Treasurer and Principal Financial Officer